Tell us what's important to you. We'll build you a better ClevelandClinic.org.

close

Take the ClevelandClinic.org Improvement Survey Now!

Online Health Chat.Access Our A-Z Phone Directorybenefiting the communityOnline Health Chat.

Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")

Print this ContentEmail this Content
Study:

Assessment of the Safety, Side Effects and Efficacy of Interventional Cryotherapy for the Eradication of Benign Airway Disease("ICE THE BAD")

Rationale:

n/a

Purpose:

The purpose of this study is to evaluate the safety, effectiveness, and side effects of the CryoSpray AblationTM System (CryoSpray AblationTM, "CSA" or "cryospray therapy") to treat benign airway disease in the lung using liquid nitrogen sprayed through a catheter via flexible fiber optic bronchoscopy (FFB)

Study Status: Not yet recruiting

Recruiting:
n/a

Condition Intervention Phase
Benign Airway Disease
Sarcoidosis
Wegener`s Granulomatosis
Rhinoscleroma
Recurrent Respiratory Papillomatosis(RRP)		 Device: CryoSpray Ablation (tm) Phase 4

Verified by CSA Medical, Inc. September, 2008

Sponsored by: CSA Medical, Inc.
Information provided by: CSA Medical, Inc.
ClinicalTrials.gov identifier: NCT00747461

Study Type: Interventional

Study Design: Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Safety/Efficacy Study

Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States

Michael Machuzak, M.D.., Principal Investigator

This information is abbridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.